Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Kidney Diseases
JournalCitation impact & published research
Kidney Diseases is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 563 works, 9,017 citations, an h-index of 49 and an APC (USD) of 2,320.
563
Works
9,017
Citations
49
h-index
2,320
APC (USD)
IDs:OpenAlex
What are the most-cited papers on Kidney Diseases?
ScholarIQmost cited works
Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China
Jinhua Hou, Hui‐Xian Zhu, Minlin Zhou, Weibo Le, Caihong Zeng, Shaoshan Liang, Feng Xu, Dandan Liang, Sijia Shao, Ye Liu, Zhi-Hong Liu
Kidney Diseases. 2017185 CitationsOPEN ACCESS
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Lu Zhou, Xian Xue, Qing Hou, Chunsun Dai
Kidney Diseases. 2021109 CitationsOPEN ACCESS
Lupus Nephritis in Asia: Clinical Features and Management
Desmond Y. H. Yap, Tak Mao Chan
Kidney Diseases. 2015103 CitationsOPEN ACCESS
Development of an Artificial Intelligence Model to Guide the Management of Blood Pressure, Fluid Volume, and Dialysis Dose in End-Stage Kidney Disease Patients: Proof of Concept and First Clinical Assessment
C. Barbieri, Isabella Cattinelli, Luca Neri, Flavio Mari, Rosa Ramos, Diego Brancaccio, Bernard Canaud, Stefano Stuard
Kidney Diseases. 201884 CitationsOPEN ACCESS
Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China
Haitao Zhang, Jingyuan Xie, Chuan‐Ming Hao, Xuemei Li, Dalong Zhu, Hongguang Zheng, Xudong Xu, Zhaohui Mo, Weiping Lu, Yibing Lu, Chao-Qing Wu, Nanwei Tong, Li Wang, Zhihong Liu
Kidney Diseases. 202319 CitationsOPEN ACCESS
Related on ScholarIQ
Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China
Paper
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
Paper
Lupus Nephritis in Asia: Clinical Features and Management
Paper
Development of an Artificial Intelligence Model to Guide the Management of Blood Pressure, Fluid Volume, and Dialysis Dose in End-Stage Kidney Disease Patients: Proof of Concept and First Clinical Assessment
Paper
Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes: The FIDELIO-DKD Subgroup from China
Paper
Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis
Paper